Anantha Shekhar - Publications

Affiliations: 
Psychiatry Indiana University School of Medicine, Indianapolis, IN, United States 
Area:
Schizophrenia, anxiety
Website:
http://www.indiana.edu/~alldrp/members/shekhar.html

107 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Salvadore G, Bonaventure P, Shekhar A, Johnson PL, Lord B, Shireman BT, Lebold TP, Nepomuceno D, Dugovic C, Brooks S, Zuiker R, Bleys C, Tatikola K, Remmerie B, Jacobs GE, et al. Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans. Translational Psychiatry. 10: 308. PMID 32895369 DOI: 10.1038/S41398-020-00937-9  0.344
2020 Bernabe CS, Caliman IF, Truitt WA, Molosh AI, Lowry CA, Hay-Schmidt A, Shekhar A, Johnson PL. Using loss- and gain-of-function approaches to target amygdala-projecting serotonergic neurons in the dorsal raphe nucleus that enhance anxiety-related and conditioned fear behaviors. Journal of Psychopharmacology (Oxford, England). 269881119900981. PMID 32153226 DOI: 10.1177/0269881119900981  0.326
2020 Patel J, Dustrude E, Haulcomb M, Li L, Jiang G, Liu Y, Lai Y, Molosh A, Shekhar A. Role of PSD95 and nNOS Interaction in Gene Regulation following Fear Conditioning and Implications for Molecular Mechanisms Underlying Post-Traumatic Stress Disorder Biological Psychiatry. 87: S334. DOI: 10.1016/J.Biopsych.2020.02.858  0.307
2019 Niculescu AB, Le-Niculescu H, Roseberry K, Wang S, Hart J, Kaur A, Robertson H, Jones T, Strasburger A, Williams A, Kurian SM, Lamb B, Shekhar A, Lahiri DK, Saykin AJ. Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs. Molecular Psychiatry. PMID 31792364 DOI: 10.1038/S41380-019-0602-2  0.31
2019 Shekhar A. Role of Kappa Opioid Receptors in Symptoms of Schizophrenia: What Is the Neurobiology? Biological Psychiatry. 86: 494-496. PMID 31521206 DOI: 10.1016/J.Biopsych.2019.08.004  0.302
2019 Donner NC, Mani S, Fitz SD, Kienzle DM, Shekhar A, Lowry CA. Crh receptor priming in the bed nucleus of the stria terminalis induces tph2 gene expression in the dorsomedial dorsal raphe nucleus and chronic anxiety. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109730. PMID 31415826 DOI: 10.1016/J.Pnpbp.2019.109730  0.332
2019 Johnson PL, Molosh AI, Federici LM, Bernabe C, Haggerty D, Fitz SD, Nalivaiko E, Truitt W, Shekhar A. Assessment of fear and anxiety associated behaviors, physiology and neural circuits in rats with reduced serotonin transporter (SERT) levels. Translational Psychiatry. 9: 33. PMID 30670681 DOI: 10.1038/S41398-019-0368-Y  0.771
2019 Molosh A, Dustrude E, Lukkes J, Truitt W, Bhatnagar S, Donck Lv, Kent J, Ceusters M, Bonaventure P, Johnson P, Shekhar A. 74. Mechanisms of Agoraphobia: Contribution of Orexin and mGluR2 Signaling in the Amygdala Biological Psychiatry. 85: S30-S31. DOI: 10.1016/J.Biopsych.2019.03.088  0.66
2018 Dustrude ET, Caliman IF, Bernabe CS, Fitz SD, Grafe LA, Bhatnagar S, Bonaventure P, Johnson PL, Molosh AI, Shekhar A. Orexin Depolarizes Central Amygdala Neurons via Orexin Receptor 1, Phospholipase C and Sodium-Calcium Exchanger and Modulates Conditioned Fear. Frontiers in Neuroscience. 12: 934. PMID 30618563 DOI: 10.3389/Fnins.2018.00934  0.307
2018 Molosh AI, Shekhar A. Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms. Progress in Brain Research. 241: 37-62. PMID 30447756 DOI: 10.1016/Bs.Pbr.2018.09.014  0.322
2018 Drozd HP, Karathanasis SF, Molosh AI, Lukkes JL, Clapp DW, Shekhar A. From bedside to bench and back: Translating ASD models. Progress in Brain Research. 241: 113-158. PMID 30447753 DOI: 10.1016/Bs.Pbr.2018.10.003  0.696
2018 Patel J, Lukkes JL, Shekhar A. Overview of genetic models of autism spectrum disorders. Progress in Brain Research. 241: 1-36. PMID 30447752 DOI: 10.1016/Bs.Pbr.2018.10.002  0.706
2018 Shekhar A, Thakur GA. Cannabinoid Receptor 1 Positive Allosteric Modulators for Posttraumatic Stress Disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 43: 226-227. PMID 29192662 DOI: 10.1038/Npp.2017.230  0.307
2017 Niculescu AB, Le-Niculescu H, Levey DF, Phalen PL, Dainton HL, Roseberry K, Niculescu EM, Niezer JO, Williams A, Graham DL, Jones TJ, Venugopal V, Ballew A, Yard M, Gelbart T, ... ... Shekhar A, et al. Precision medicine for suicidality: from universality to subtypes and personalization. Molecular Psychiatry. PMID 28809398 DOI: 10.1038/Mp.2017.128  0.314
2017 Forster SE, Zirnheld P, Shekhar A, Steinhauer SR, O'Donnell BF, Hetrick WP. Event-related potentials reflect impaired temporal interval learning following haloperidol administration. Psychopharmacology. PMID 28601965 DOI: 10.1007/S00213-017-4645-2  0.654
2017 Lukkes JL, Molosh AI, Shekhar A. Sex-dependent effects of adolescent social stress on depressive behavior and stress-related neurocircuitry Psychoneuroendocrinology. 83: 88. DOI: 10.1016/J.Psyneuen.2017.07.476  0.664
2015 Johnson PL, Molosh A, Fitz SD, Arendt D, Deehan GA, Federici LM, Bernabe C, Engleman EA, Rodd ZA, Lowry CA, Shekhar A. Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning. Pharmacology, Biochemistry, and Behavior. 138: 174-9. PMID 26476009 DOI: 10.1016/J.Pbb.2015.09.021  0.317
2015 Goddard AW, Mahmud W, Medlock C, Shin YW, Shekhar A. A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder. Annals of General Psychiatry. 14: 26. PMID 26379759 DOI: 10.1186/S12991-015-0064-0  0.319
2015 Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N, Belanger E, James A, George S, Weber H, Graham DL, Schweitzer R, Ladd TB, Learman R, Niculescu EM, ... ... Shekhar A, et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Molecular Psychiatry. PMID 26283638 DOI: 10.1038/Mp.2015.112  0.313
2015 Bonaventure P, Yun S, Johnson PL, Shekhar A, Fitz SD, Shireman BT, Lebold TP, Nepomuceno D, Lord B, Wennerholm M, Shelton J, Carruthers N, Lovenberg T, Dugovic C. A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects. The Journal of Pharmacology and Experimental Therapeutics. 352: 590-601. PMID 25583879 DOI: 10.1124/Jpet.114.220392  0.303
2014 Johnson PL, Federici LM, Shekhar A. Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks. Neuroscience and Biobehavioral Reviews. 46: 429-54. PMID 25130976 DOI: 10.1016/J.Neubiorev.2014.07.027  0.305
2014 Shekhar A. Angiotensin type 1 receptor antagonists-a novel approach to augmenting posttraumatic stress disorder and phobia therapies? Biological Psychiatry. 75: 836-7. PMID 24837620 DOI: 10.1016/J.Biopsych.2014.04.004  0.337
2014 Paul ED, Johnson PL, Shekhar A, Lowry CA. The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic. Neuroscience and Biobehavioral Reviews. 46: 379-96. PMID 24661986 DOI: 10.1016/J.Neubiorev.2014.03.010  0.341
2014 Lungwitz EA, Stuber GD, Johnson PL, Dietrich AD, Schartz N, Hanrahan B, Shekhar A, Truitt WA. The role of the medial prefrontal cortex in regulating social familiarity-induced anxiolysis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1009-19. PMID 24157502 DOI: 10.1038/Npp.2013.302  0.308
2013 Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N, Winiger E, Bhosrekar S, Shankar G, Radel M, Bellanger E, Duckworth H, Olesek K, Vergo J, Schweitzer R, ... ... Shekhar A, et al. Discovery and validation of blood biomarkers for suicidality. Molecular Psychiatry. 18: 1249-64. PMID 23958961 DOI: 10.1038/Mp.2013.95  0.322
2013 Johannesen JK, O'Donnell BF, Shekhar A, McGrew JH, Hetrick WP. Diagnostic specificity of neurophysiological endophenotypes in schizophrenia and bipolar disorder. Schizophrenia Bulletin. 39: 1219-29. PMID 22927673 DOI: 10.1093/Schbul/Sbs093  0.697
2012 Lungwitz EA, Molosh A, Johnson PL, Harvey BP, Dirks RC, Dietrich A, Minick P, Shekhar A, Truitt WA. Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiology & Behavior. 107: 726-32. PMID 22652097 DOI: 10.1016/J.Physbeh.2012.05.019  0.314
2012 Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Molecular Psychiatry. 17: 887-905. PMID 22584867 DOI: 10.1038/Mp.2012.37  0.383
2012 Johnson PL, Samuels BC, Fitz SD, Federici LM, Hammes N, Early MC, Truitt W, Lowry CA, Shekhar A. Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiology & Behavior. 107: 733-42. PMID 22554617 DOI: 10.1016/J.Physbeh.2012.04.016  0.363
2012 Hale MW, Shekhar A, Lowry CA. Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Cellular and Molecular Neurobiology. 32: 695-708. PMID 22484834 DOI: 10.1007/S10571-012-9827-1  0.328
2012 Johnson PL, Shekhar A. An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus. Physiology & Behavior. 107: 686-98. PMID 22484112 DOI: 10.1016/J.Physbeh.2012.03.016  0.391
2012 Johnson PL, Samuels BC, Fitz SD, Lightman SL, Lowry CA, Shekhar A. Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1911-22. PMID 22453138 DOI: 10.1038/Npp.2012.38  0.324
2012 Bolbecker AR, Shekhar A. Muscarinic agonists and antagonists in schizophrenia: recent therapeutic advances and future directions. Handbook of Experimental Pharmacology. 167-90. PMID 22222699 DOI: 10.1007/978-3-642-23274-9_8  0.367
2011 Le-Niculescu H, Balaraman Y, Patel SD, Ayalew M, Gupta J, Kuczenski R, Shekhar A, Schork N, Geyer MA, Niculescu AB. Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Translational Psychiatry. 1: e9. PMID 22832404 DOI: 10.1038/Tp.2011.9  0.4
2011 Snyder AN, Bockbrader MA, Hoffa AM, Dzemidzic MA, Talavage TM, Wong D, Lowe MJ, O'Donnell BF, Shekhar A. Psychometrically matched tasks evaluating differential fMRI activation during form and motion processing. Neuropsychology. 25: 622-33. PMID 21534685 DOI: 10.1037/A0022984  0.528
2011 Lukkes JL, Staub DR, Dietrich A, Truitt W, Neufeld-Cohen A, Chen A, Johnson PL, Shekhar A, Lowry CA. Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase. Neuroscience. 183: 47-63. PMID 21453754 DOI: 10.1016/J.Neuroscience.2011.03.047  0.672
2011 Shekhar A, Johnson PL, Fitz SD, Nakazato A, Chaki S, Steckler T, Schmidt M. A selective, non-peptide CRF receptor 1 antagonist prevents sodium lactate-induced acute panic-like responses. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 355-65. PMID 21087553 DOI: 10.1017/S1461145710001355  0.355
2010 Rass O, Krishnan G, Brenner CA, Hetrick WP, Merrill CC, Shekhar A, O'Donnell BF. Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders. Bipolar Disorders. 12: 793-803. PMID 21176026 DOI: 10.1111/J.1399-5618.2010.00871.X  0.707
2010 Shin YW, Krishnan G, Hetrick WP, Brenner CA, Shekhar A, Malloy FW, O'Donnell BF. Increased temporal variability of auditory event-related potentials in schizophrenia and Schizotypal Personality Disorder. Schizophrenia Research. 124: 110-8. PMID 20817485 DOI: 10.1016/J.Schres.2010.08.008  0.712
2010 Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, Wu X, Gentile KA, Huang SP, Emison E, Delmonte T, D'Souza BB, Zimbroff DL, Grebb JA, Goddard AW, et al. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depression and Anxiety. 27: 417-25. PMID 20455246 DOI: 10.1002/Da.20695  0.302
2010 Molosh AI, Johnson PL, Fitz SD, Dimicco JA, Herman JP, Shekhar A. Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1333-47. PMID 20130534 DOI: 10.1038/Npp.2010.2  0.374
2010 Goddard AW, Ball SG, Martinez J, Robinson MJ, Yang CR, Russell JM, Shekhar A. Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depression and Anxiety. 27: 339-50. PMID 19960531 DOI: 10.1002/Da.20642  0.306
2010 Chambers RA, Sentir AM, Conroy SK, Truitt WA, Shekhar A. Cortical-striatal integration of cocaine history and prefrontal dysfunction in animal modeling of dual diagnosis. Biological Psychiatry. 67: 788-92. PMID 19880093 DOI: 10.1016/J.Biopsych.2009.09.006  0.326
2009 Fridberg DJ, Hetrick WP, Brenner CA, Shekhar A, Steffen AN, Malloy FW, O'Donnell BF. Relationships between auditory event-related potentials and mood state, medication, and comorbid psychiatric illness in patients with bipolar disorder. Bipolar Disorders. 11: 857-66. PMID 19922554 DOI: 10.1111/J.1399-5618.2009.00758.X  0.698
2009 Carroll CA, O'Donnell BF, Shekhar A, Hetrick WP. Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task. Brain and Cognition. 71: 345-53. PMID 19664870 DOI: 10.1016/J.Bandc.2009.06.009  0.699
2009 Brenner CA, Kieffaber PD, Clementz BA, Johannesen JK, Shekhar A, O'Donnell BF, Hetrick WP. Event-related potential abnormalities in schizophrenia: a failure to "gate in" salient information? Schizophrenia Research. 113: 332-8. PMID 19628376 DOI: 10.1016/J.Schres.2009.06.012  0.696
2009 Krishnan GP, Hetrick WP, Brenner CA, Shekhar A, Steffen AN, O'Donnell BF. Steady state and induced auditory gamma deficits in schizophrenia. Neuroimage. 47: 1711-9. PMID 19371786 DOI: 10.1016/J.Neuroimage.2009.03.085  0.683
2009 Carroll CA, O'Donnell BF, Shekhar A, Hetrick WP. Timing dysfunctions in schizophrenia span from millisecond to several-second durations. Brain and Cognition. 70: 181-90. PMID 19282082 DOI: 10.1016/J.Bandc.2009.02.001  0.696
2009 Bolbecker AR, Hetrick WP, Johannesen JK, O'Donnell BF, Steinmetz JE, Shekhar AS. Secretin effects on cerebellar-dependent motor learning in schizophrenia. The American Journal of Psychiatry. 166: 460-6. PMID 19223439 DOI: 10.1176/Appi.Ajp.2008.08040597  0.664
2009 Bolbecker AR, Mehta C, Johannesen JK, Edwards CR, O'Donnell BF, Shekhar A, Nurnberger JI, Steinmetz JE, Hetrick WP. Eyeblink conditioning anomalies in bipolar disorder suggest cerebellar dysfunction. Bipolar Disorders. 11: 19-32. PMID 19133963 DOI: 10.1111/J.1399-5618.2008.00642.X  0.691
2008 Lowry CA, Hale MW, Evans AK, Heerkens J, Staub DR, Gasser PJ, Shekhar A. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Annals of the New York Academy of Sciences. 1148: 86-94. PMID 19120094 DOI: 10.1196/Annals.1410.004  0.331
2008 Carroll CA, Kieffaber PD, Vohs JL, O'Donnell BF, Shekhar A, Hetrick WP. Contributions of spectral frequency analyses to the study of P50 ERP amplitude and suppression in bipolar disorder with or without a history of psychosis. Bipolar Disorders. 10: 776-87. PMID 19032709 DOI: 10.1111/J.1399-5618.2008.00622.X  0.702
2008 Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dubé S, Mallinckrodt C, Bymaster FP, McKinzie DL, Felder CC. Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. The American Journal of Psychiatry. 165: 1033-9. PMID 18593778 DOI: 10.1176/Appi.Ajp.2008.06091591  0.368
2008 Goddard AW, Shekhar A, Whiteman AF, McDougle CJ. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discovery Today. 13: 325-32. PMID 18405845 DOI: 10.1016/J.Drudis.2007.12.009  0.311
2008 Sajdyk T, Johnson P, Fitz S, Shekhar A. Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior. Journal of Psychopharmacology (Oxford, England). 22: 633-41. PMID 18308797 DOI: 10.1177/0269881107082902  0.305
2008 Johnson P, Lowry C, Truitt W, Shekhar A. Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic. Journal of Psychopharmacology (Oxford, England). 22: 642-52. PMID 18308791 DOI: 10.1177/0269881107082900  0.309
2008 Hayden EP, Bodkins M, Brenner C, Shekhar A, Nurnberger JI, O'Donnell BF, Hetrick WP. A multimethod investigation of the behavioral activation system in bipolar disorder. Journal of Abnormal Psychology. 117: 164-70. PMID 18266494 DOI: 10.1037/0021-843X.117.1.164  0.689
2008 Vohs JL, Hetrick WP, Kieffaber PD, Bodkins M, Bismark A, Shekhar A, O'Donnell BF. Visual event-related potentials in schizotypal personality disorder and schizophrenia. Journal of Abnormal Psychology. 117: 119-31. PMID 18266490 DOI: 10.1037/0021-843X.117.1.119  0.696
2008 Johannesen JK, Bodkins M, O'Donnell BF, Shekhar A, Hetrick WP. Perceptual anomalies in schizophrenia co-occur with selective impairments in the gamma frequency component of midlatency auditory ERPs. Journal of Abnormal Psychology. 117: 106-18. PMID 18266489 DOI: 10.1037/0021-843X.117.1.106  0.694
2008 Carroll CA, Boggs J, O'Donnell BF, Shekhar A, Hetrick WP. Temporal processing dysfunction in schizophrenia. Brain and Cognition. 67: 150-61. PMID 18262701 DOI: 10.1016/J.Bandc.2007.12.005  0.7
2008 Edwards CR, Newman S, Bismark A, Skosnik PD, O'Donnell BF, Shekhar A, Steinmetz JE, Hetrick WP. Cerebellum volume and eyeblink conditioning in schizophrenia. Psychiatry Research. 162: 185-94. PMID 18222655 DOI: 10.1016/J.Pscychresns.2007.06.001  0.693
2008 Ascher-Svanum H, Nyhuis AW, Faries DE, Kinon BJ, Baker RW, Shekhar A. Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia. Schizophrenia Bulletin. 34: 1163-71. PMID 18156640 DOI: 10.1093/Schbul/Sbm134  0.345
2007 Chambers RA, Sajdyk TJ, Conroy SK, Lafuze JE, Fitz SD, Shekhar A. Neonatal amygdala lesions: co-occurring impact on social/fear-related behavior and cocaine sensitization in adult rats. Behavioral Neuroscience. 121: 1316-27. PMID 18085884 DOI: 10.1037/0735-7044.121.6.1316  0.313
2007 Kieffaber PD, O'Donnell BF, Shekhar A, Hetrick WP. Event related brain potential evidence for preserved attentional set switching in schizophrenia. Schizophrenia Research. 93: 355-65. PMID 17466490 DOI: 10.1016/J.Schres.2007.03.018  0.683
2007 Carroll CA, Vohs JL, O'donnell BF, Shekhar A, Hetrick WP. Sensorimotor gating in manic and mixed episode bipolar disorder. Bipolar Disorders. 9: 221-9. PMID 17430296 DOI: 10.1111/J.1399-5618.2007.00415.X  0.715
2007 Truitt WA, Sajdyk TJ, Dietrich AD, Oberlin B, McDougle CJ, Shekhar A. From anxiety to autism: spectrum of abnormal social behaviors modeled by progressive disruption of inhibitory neuronal function in the basolateral amygdala in Wistar rats. Psychopharmacology. 191: 107-18. PMID 17277936 DOI: 10.1007/S00213-006-0674-Y  0.337
2007 Lee Y, Gaskins D, Anand A, Shekhar A. Glia mechanisms in mood regulation: a novel model of mood disorders. Psychopharmacology. 191: 55-65. PMID 17225169 DOI: 10.1007/S00213-006-0652-4  0.362
2007 Tohen M, Vieta E, Amsterdam JJ, Aaronson ST, Sun B, Bowden C, Banov M, Shekhar A, Oliff HS, Kryzhanovskaya L. P.2.f.002 Olanzapine versus divalproex and placebo for the treatment of mild to moderate mania associated with bipolar I disorder European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70577-1  0.319
2006 O'Donnell BF, Bismark A, Hetrick WP, Bodkins M, Vohs JL, Shekhar A. Early stage vision in schizophrenia and schizotypal personality disorder. Schizophrenia Research. 86: 89-98. PMID 16829048 DOI: 10.1016/J.Schres.2006.05.016  0.7
2006 Evans AK, Abrams JK, Bouwknecht JA, Knight DM, Shekhar A, Lowry CA. The anxiogenic drug FG-7142 increases serotonin metabolism in the rat medial prefrontal cortex. Pharmacology, Biochemistry, and Behavior. 84: 266-74. PMID 16784772 DOI: 10.1016/J.Pbb.2006.05.007  0.306
2006 Sajdyk TJ, Fitz SD, Shekhar A. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress (Amsterdam, Netherlands). 9: 21-8. PMID 16753930 DOI: 10.1080/10253890600557315  0.311
2006 Kieffaber PD, Kappenman ES, Bodkins M, Shekhar A, O'Donnell BF, Hetrick WP. Switch and maintenance of task set in schizophrenia. Schizophrenia Research. 84: 345-58. PMID 16563700 DOI: 10.1016/J.Schres.2006.01.022  0.682
2006 Spiga F, Lightman SL, Shekhar A, Lowry CA. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons. Neuroscience. 138: 1265-76. PMID 16488545 DOI: 10.1016/J.Neuroscience.2005.12.051  0.308
2005 Lowry CA, Johnson PL, Hay-Schmidt A, Mikkelsen J, Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress (Amsterdam, Netherlands). 8: 233-46. PMID 16423712 DOI: 10.1080/10253890500492787  0.301
2005 Shekhar A, Truitt W, Rainnie D, Sajdyk T. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress (Amsterdam, Netherlands). 8: 209-19. PMID 16423710 DOI: 10.1080/10253890500504557  0.324
2005 Johannesen JK, Kieffaber PD, O'Donnell BF, Shekhar A, Evans JD, Hetrick WP. Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophrenia Research. 78: 269-84. PMID 16002265 DOI: 10.1016/J.Schres.2005.05.022  0.7
2005 Abrams JK, Johnson PL, Hay-Schmidt A, Mikkelsen JD, Shekhar A, Lowry CA. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience. 133: 983-97. PMID 15916857 DOI: 10.1016/J.Neuroscience.2005.03.025  0.309
2005 Brown SM, Kieffaber PD, Carroll CA, Vohs JL, Tracy JA, Shekhar A, O'Donnell BF, Steinmetz JE, Hetrick WP. Eyeblink conditioning deficits indicate timing and cerebellar abnormalities in schizophrenia. Brain and Cognition. 58: 94-108. PMID 15878730 DOI: 10.1016/J.Bandc.2004.09.011  0.704
2005 Gehlert DR, Shekhar A, Morin SM, Hipskind PA, Zink C, Gackenheimer SL, Shaw J, Fitz SD, Sajdyk TJ. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. European Journal of Pharmacology. 509: 145-53. PMID 15733549 DOI: 10.1016/J.Ejphar.2004.12.030  0.325
2005 Krishnan GP, Vohs JL, Hetrick WP, Carroll CA, Shekhar A, Bockbrader MA, O'Donnell BF. Steady state visual evoked potential abnormalities in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 116: 614-24. PMID 15721075 DOI: 10.1016/J.Clinph.2004.09.016  0.675
2005 Ball SG, Kuhn A, Wall D, Shekhar A, Goddard AW. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline. The Journal of Clinical Psychiatry. 66: 94-9. PMID 15669894 DOI: 10.4088/Jcp.V66N0113  0.32
2004 Zirnheld PJ, Carroll CA, Kieffaber PD, O'Donnell BF, Shekhar A, Hetrick WP. Haloperidol impairs learning and error-related negativity in humans. Journal of Cognitive Neuroscience. 16: 1098-112. PMID 15298795 DOI: 10.1162/0898929041502779  0.658
2004 Koss WA, Gehlert DR, Shekhar A. Different effects of subchronic doses of 17-beta estradiol in two ethologically based models of anxiety utilizing female rats. Hormones and Behavior. 46: 158-64. PMID 15256305 DOI: 10.1016/J.Yhbeh.2004.02.011  0.304
2004 O'Donnell BF, Vohs JL, Hetrick WP, Carroll CA, Shekhar A. Auditory event-related potential abnormalities in bipolar disorder and schizophrenia. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 53: 45-55. PMID 15172135 DOI: 10.1016/J.Ijpsycho.2004.02.001  0.718
2004 O'Donnell BF, Hetrick WP, Vohs JL, Krishnan GP, Carroll CA, Shekhar A. Neural synchronization deficits to auditory stimulation in bipolar disorder. Neuroreport. 15: 1369-72. PMID 15167568 DOI: 10.1097/01.Wnr.0000127348.64681.B2  0.702
2004 Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3471-9. PMID 15071094 DOI: 10.1523/Jneurosci.5740-03.2004  0.336
2004 Carroll CA, O'Donnell BF, Shekhar A, Hetrick WP. The effects of olanzapine on sensory gating in healthy participants. Schizophrenia Research. 66: 187-9. PMID 15061253 DOI: 10.1016/S0920-9964(03)00149-X  0.636
2003 Sajdyk TJ, Keim SR, Thielen SR, Fitz SD, Shekhar A. Measurement of panic-like responses following intravenous infusion of sodium lactate in panic-prone rats. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.17. PMID 18428590 DOI: 10.1002/0471142301.Ns0917S24  0.362
2003 Beglinger LJ, Ahmed S, Derby MA, Siemers E, Fastenau PS, Crawford-Miller J, Shekhar A, Kareken DA. Neuropsychological practice effects and change detection in people with schizophrenia. Schizophrenia Research. 62: 191-4. PMID 12765761 DOI: 10.1016/S0920-9964(02)00425-5  0.313
2003 Anand A, Shekhar A. Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Annals of the New York Academy of Sciences. 985: 370-88. PMID 12724172 DOI: 10.1111/J.1749-6632.2003.Tb07095.X  0.342
2003 Shekhar A, Sajdyk TJ, Gehlert DR, Rainnie DG. The amygdala, panic disorder, and cardiovascular responses. Annals of the New York Academy of Sciences. 985: 308-25. PMID 12724167 DOI: 10.1111/J.1749-6632.2003.Tb07090.X  0.341
2002 Sweeten TL, Posey DJ, Shekhar A, McDougle CJ. The amygdala and related structures in the pathophysiology of autism. Pharmacology, Biochemistry, and Behavior. 71: 449-55. PMID 11830179 DOI: 10.1016/S0091-3057(01)00697-9  0.349
2002 Thielen SK, Shekhar A. Amygdala priming results in conditioned place avoidance. Pharmacology, Biochemistry, and Behavior. 71: 401-6. PMID 11830174 DOI: 10.1016/S0091-3057(01)00696-7  0.333
2001 Shekhar A, McCann UD, Meaney MJ, Blanchard DC, Davis M, Frey KA, Liberzon I, Overall KL, Shear MK, Tecott LH, Winsky L. Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders. Psychopharmacology. 157: 327-39. PMID 11605091 DOI: 10.1007/S002130100859  0.34
2000 Sajdyk TJ, Shekhar A. Sodium lactate elicits anxiety in rats after repeated GABA receptor blockade in the basolateral amygdala. European Journal of Pharmacology. 394: 265-73. PMID 10771292 DOI: 10.1016/S0014-2999(00)00128-X  0.329
2000 Shekhar A, Keim SR. LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats. Neuropharmacology. 39: 1139-46. PMID 10760357 DOI: 10.1016/S0028-3908(99)00215-4  0.328
1999 Shekhar A, Sajdyk TS, Keim SR, Yoder KK, Sanders SK. Role of the basolateral amygdala in panic disorder. Annals of the New York Academy of Sciences. 877: 747-50. PMID 10415697 DOI: 10.1111/J.1749-6632.1999.Tb09315.X  0.338
1999 Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behavioural Brain Research. 100: 207-15. PMID 10212068 DOI: 10.1016/S0166-4328(98)00132-6  0.337
1997 Ball S, Robinson A, Shekhar A, Walsh K. Dissociative symptoms in panic disorder. The Journal of Nervous and Mental Disease. 185: 755-60. PMID 9442187 DOI: 10.1097/00005053-199712000-00006  0.357
1997 Shekhar A, Keim SR. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 9726-35. PMID 9391025 DOI: 10.1523/Jneurosci.17-24-09726.1997  0.328
1997 Ball S, Shekhar A. Basilar artery response to hyperventilation in panic disorder. The American Journal of Psychiatry. 154: 1603-4. PMID 9356573 DOI: 10.1176/Ajp.154.11.1603  0.316
1997 Sajdyk TJ, Katner JS, Shekhar A. Monoamines in the dorsomedial hypothalamus of rats following exposure to different tests of "anxiety". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 21: 193-209. PMID 9075267 DOI: 10.1016/S0278-5846(96)00138-8  0.3
1996 Gould RA, Ball S, Kaspi SP, Otto MW, Pollack MH, Shekhar A, Fava M. Prevalence and correlates of anger attacks: a two site study. Journal of Affective Disorders. 39: 31-8. PMID 8835651 DOI: 10.1016/0165-0327(96)00017-1  0.337
1995 Sanders SK, Morzorati SL, Shekhar A. Priming of experimental anxiety by repeated subthreshold GABA blockade in the rat amygdala. Brain Research. 699: 250-9. PMID 8616628 DOI: 10.1016/0006-8993(95)00915-D  0.319
1995 Ball SG, Buchwald AM, Waddell MT, Shekhar A. Depression and generalized anxiety symptoms in panic disorder. Implications for comorbidity. The Journal of Nervous and Mental Disease. 183: 304-8. PMID 7745384 DOI: 10.1097/00005053-199505000-00005  0.32
1994 Shekhar A. Effects of treatment with imipramine and clonazepam on an animal model of panic disorder. Biological Psychiatry. 36: 748-58. PMID 7858071 DOI: 10.1016/0006-3223(94)90086-8  0.317
1993 Shekhar A. GABA receptors in the region of the dorsomedial hypothalamus of rats regulate anxiety in the elevated plus-maze test. I. Behavioral measures. Brain Research. 627: 9-16. PMID 8293308 DOI: 10.1016/0006-8993(93)90742-6  0.301
Show low-probability matches.